Odonate Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Odonate

14/05/2021 22:19

* Odonate Therapeutics Inc  ODT.OQ  reported a quarterly
adjusted loss of 90 cents​​ per share for the quarter ended
in March. The mean expectation of three analysts for the quarter
was for a loss of 81 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Odonate Therapeutics Inc's reported EPS for the quarter was a
loss of 90 cents​.
* The mean earnings estimate of analysts had fallen by
about 1.1% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Odonate Therapeutics Inc shares had fallen by 12.6% this
quarter and lost 84.4% so far this year.
* The company reported a quarterly loss of $33.77 million.
* Wall Street's median 12-month price target for Odonate
Therapeutics Inc is $4.00 
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is no "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 
This summary was machine generated May 14 at 09:19 p.m. GMT.
​All figures in US dollars